ClinicalTrials.Veeva

Menu
R

Revival Research | Doral, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ASN002
Vibegron
Upadacitinib
ABP 501
PF-07275315
SHR-1314
Humira®
Tolterodine Tartrate
LY3454738
Guselkumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials
Locations recently updated

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Enrolling
Alopecia Areata
Drug: Upadacitinib
Drug: Placebo

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07264660
Drug: PF-07275315
Locations recently updated

The purpose of this study is to evaluate the efficacy of guselkumab compared to an inactive drug in participants with low body surface area moderate...

Enrolling
Moderate Plaque Psoriasis
Drug: Placebo
Drug: Guselkumab

Trial sponsors

AbbVie logo
Amgen logo
A
U
Hengrui Medicine logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Moderna logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems